Beijing Scitop Bio-tech Co., Ltd.

SZSE:300858 Stock Report

Market Cap: CN¥3.5b

Beijing Scitop Bio-tech Valuation

Is 300858 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Share Price vs Fair Value

What is the Fair Price of 300858 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
CN¥1.48
Fair Value
793.9% overvalued intrinsic discount
1
Number of Analysts


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300858?

Key metric:

The above table shows the Price to Earnings ratio for 300858. This is calculated by dividing 300858's market cap by their current earnings.
What is 300858's PE Ratio?
PE Ratio37.7x
EarningsCN¥92.67m
Market CapCN¥3.54b

Price to Earnings Ratio vs Peers

How does 300858's PE Ratio compare to its peers?

The above table shows the PE ratio for 300858 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average42.8x
000639 Xiwang FoodstuffsLtd
93.1xn/aCN¥3.7b
603237 Zhejiang Wufangzhai Industry
25.8x16.2%CN¥3.5b
000529 Guangdong Guanghong HoldingsLtd
23.4xn/aCN¥3.3b
001318 Jiangxi Sunshine Dairy
28.9xn/aCN¥3.1b
300858 Beijing Scitop Bio-tech
37.7x42.6%CN¥3.5b


Price to Earnings Ratio vs Industry

How does 300858's PE Ratio compare vs other companies in the CN Food Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
002157 Jiangxi Zhengbang TechnologyLtd
2.2xn/aUS$3.50b
600872 Jonjee Hi-Tech Industrial and Commercial HoldingLtd
4.7x-46.4%US$2.30b
002086 Shandong Oriental Ocean Sci-Tech
2.8xn/aUS$663.46m
No more companies available in this PE range
300858 37.7xIndustry Avg. 29.8xNo. of Companies19PE020406080100+
3 CompaniesEstimated GrowthMarket Cap
No more companies


Price to Earnings Ratio vs Fair Ratio

What is 300858's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300858 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio37.7x
Fair PE Ratio32.3x


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Price Target
Consensus Narrative from 1 Analyst
CN¥17.67
Fair Value
25.0% undervalued intrinsic discount
1
Number of Analysts


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 14:00
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beijing Scitop Bio-tech Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wendan WangChina International Capital Corporation Limited
Wende WuTianfeng Securities Brokerage Co., Ltd